Literature DB >> 29737528

Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.

Camilla Sköld1, Tone Bjørge2,3, Anders Ekbom4, Anders Engeland2,5, Mika Gissler6,7, Tom Grotmol3, Laura Madanat-Harjuoja8,9, Anne Gulbech Ording10, Olof Stephansson4, Britton Trabert11, Steinar Tretli3, Rebecca Troisi11, Henrik Toft Sørensen10, Ingrid Glimelius1,4.   

Abstract

Epithelial ovarian cancer is a fatal disease of largely unknown etiology. Higher parity is associated with reduced risk of ovarian cancer. However, among parous women, the impact of pregnancy-related factors on risk is not well understood. This population-based case-control study included all parous women with epithelial ovarian cancer in Denmark, Finland, Norway and Sweden during 1967-2013 (n = 10,957) and up to 10 matched controls (n = 107,864). We used conditional logistic regression to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for pregnancy-related factors and ovarian cancer risk by histological subtype. Preterm delivery was associated with an increased risk [pregnancy length (last pregnancy) ≤30 vs. 39-41 weeks, OR 1.33 (95% CI 1.06-1.67), adjusted for number of births]; the OR increased as pregnancy length decreased (p for trend < 0.001). Older age at first and last birth was associated with a decreased risk [first birth: 30-39 vs. <25 years: adjusted OR 0.76 (95% CI 0.70-0.83); last birth 30-39 vs. <25 years: adjusted OR 0.76 (95% CI 0.71-0.82)]. Increasing number of births was protective [≥4 births vs. 1; OR 0.63 (95% CI 0.59-0.68)] for all subtypes, most pronounced for clear-cell tumors [OR 0.30, (95% CI 0.21-0.44), pheterogeneity  < 0.001]. No associations were observed for multiple pregnancies, preeclampsia or offspring size. In conclusion, in addition to high parity, full-term pregnancies and pregnancies at older ages were associated with decreased risk of ovarian cancer. Our findings favor the cell clearance hypothesis, i.e. a recent pregnancy provides protection by clearing of precancerous cells from the epithelium of the ovary/fallopian tubes, mediated by placental or ovarian hormones.
© 2018 UICC.

Entities:  

Mesh:

Year:  2018        PMID: 29737528      PMCID: PMC6128744          DOI: 10.1002/ijc.31581

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  Timing of pregnancy and the risk of epithelial ovarian cancer.

Authors:  David C Whiteman; Victor Siskind; David M Purdie; Adèle C Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

2.  International variability of ages at menarche and menopause: patterns and main determinants.

Authors:  F Thomas; F Renaud; E Benefice; T de Meeüs; J F Guegan
Journal:  Hum Biol       Date:  2001-04       Impact factor: 0.553

3.  Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s.

Authors:  K Makkonen; E Hemminki
Journal:  Scand J Soc Med       Date:  1991-03

4.  Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines.

Authors:  S Z Bu; D L Yin; X H Ren; L Z Jiang; Z J Wu; Q R Gao; G Pei
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

5.  The Danish Cancer Registry--history, content, quality and use.

Authors:  H H Storm; E V Michelsen; I H Clemmensen; J Pihl
Journal:  Dan Med Bull       Date:  1997-11

6.  Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.

Authors:  Joellen M Schildkraut; Brian Calingaert; Polly A Marchbanks; Patricia G Moorman; Gustavo C Rodriguez
Journal:  J Natl Cancer Inst       Date:  2002-01-02       Impact factor: 13.506

7.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

8.  Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.

Authors:  Lorelei A Mucci; Paul W Dickman; Mats Lambe; Hans-Olov Adami; Dimitrios Trichopoulos; Tomas Riman; Chung-Cheng Hsieh; Sven Cnattingius
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 9.  Incomplete pregnancy and risk of ovarian cancer: results from two Australian case-control studies and systematic review.

Authors:  Marie-Louise B Dick; Vic Siskind; David M Purdie; Adèle C Green
Journal:  Cancer Causes Control       Date:  2009-11       Impact factor: 2.506

Review 10.  Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.

Authors:  V Beral; K Gaitskell; C Hermon; K Moser; G Reeves; R Peto
Journal:  Lancet Oncol       Date:  2012-08-03       Impact factor: 41.316

View more
  4 in total

Review 1.  Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved.

Authors:  Claudia Main; Xinyue Chen; Min Zhao; Lawrence W Chamley; Qi Chen
Journal:  Endocrinology       Date:  2022-10-11       Impact factor: 5.051

2.  Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study.

Authors:  Britton Trabert; Rebecca Troisi; Tom Grotmol; Anders Ekbom; Anders Engeland; Mika Gissler; Ingrid Glimelius; Laura Madanat-Harjuoja; Henrik Toft Sørensen; Steinar Tretli; Anne Gulbech Ording; Tone Bjørge
Journal:  Int J Cancer       Date:  2019-06-20       Impact factor: 7.316

3.  BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.

Authors:  Sihan Chen; Zhangyun Li; Yanyan Wang; Shaohua Fan
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

4.  Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis.

Authors:  Yanjun Wu; Wenjun Sun; Xueling Xin; Weijing Wang; Dongfeng Zhang
Journal:  Biosci Rep       Date:  2019-09-13       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.